Home » ID BIOMEDICAL ANNOUNCES SALE AND LEASEBACK TRANSACTIONS
ID BIOMEDICAL ANNOUNCES SALE AND LEASEBACK TRANSACTIONS
ID Biomedical has signed agreements with Alexandria Real Estate Equities for the sale and leaseback of two ID Biomedical facilities: the newly constructed Vaccine Research Centre in Laval, Quebec, Canada; and a vaccine development facility in Northborough, Mass., U.S. The total purchase price to be paid at closing to ID Biomedical is approximately CAD $50 million. The closing of the transactions is subject to certain conditions. The company expects to close the transactions by no later than Jan. 31, 2005.
Yahoo News (http://biz.yahoo.com/prnews/050104/to295_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct